Morgan Stanley Upgrades Alder Biopharm (ALDR) to Equalweight Following Acquisition
Tweet Send to a Friend
Morgan Stanley analyst Jeffrey Hung upgraded Alder Biopharm (NASDAQ: ALDR) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
